 | • レポートコード：QYR9ST01523 • 出版社/出版日：QYResearch / 2019年9月2日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、115ページ • 納品方法：Eメール（受注後2-3営業日） • 産業分類：医薬品・医療 |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| ※本調査レポートでは、世界の心不全薬市場について調査・分析し、以下の構成でお届け致します。心不全薬の種類別には、ベータ遮断薬、ARB、ACE阻害剤に、用途別には、病院、薬局、その他に、地域別には、北米、アメリカ、ヨーロッパ、アジア、中国、日本国内、韓国、インド、中南米、中東・アフリカなどに区分してセグメント分析を行いました。 ・調査販売 ・エグゼクティブ・サマリー ・企業別心不全薬売上データ ・地域別心不全薬市場規模：北米、アメリカ、ヨーロッパ、アジア、中国、日本国内、韓国、インド、中南米、中東・アフリカ、その他 ・種類別心不全薬市場規模：ベータ遮断薬、ARB、ACE阻害剤 ・用途別心不全薬市場規模：病院、薬局、その他 ・主要メーカーの企業情報：Amgen、AstraZeneca、Bayer、Novartis、Gilead、GlaxoSmithKline、Pfizer、Teva Pharmaceutical industries ・心不全薬の市場規模予測 ・バリューチェーン及び販売チャネル分析 ・市場機会・課題・リスク・影響因子分析 ... |
The global heart failure drugs market is generic in nature; as many generic drug manufacturers and pharmaceutical giants are providing drugs for a disease. However; the arrival of innovative drugs such as EOM, is expected to change the market dynamics. AstraZeneca and Novartis hold the major share of the global heart failure drugs market with their drugs Toprol-XL and wog, respectively. The companies also hold a strong pipeline and are expected to remain the market leaders during the forecast period. Based on the drug class the market can be segmented into Beta blockers, ARBs, and ACE inhibitors. Angiotensin II receptor blockers (ARB) are a group of pharmaceuticals that modify the renin-angiotensin system. The heart disease drugs market is experiencing growth in the ARBs segment because it reduces the risk of death caused by heart failure and minimizes the chance of hospitalization of people with heart failure.The latest trend gaining momentum in the market is investment inclination toward developing countries. Countries such as India, China, and Brazil are turning out to be some of the most attractive countries for pharmaceutical companies across the globe. Many factors such as huge share of global population and rising geriatric population are leading to the high growth of healthcare sector in the developing countries. In addition, the rising cases of lifestyle disorders such as obesity and diabetes also contribute to higher heart failure cases in the region.
One of the major drivers for this market is rising geriatric population. A large number of health problems are associated with the rising age, and CVDs are major among them. As a person gets older, the blood vessels become less flexible, thus making it difficult for the blood to flow through them. Rising age accompanied by other factors such as lifestyle-oriented diseases and smoking increases the risk of CVDs, especially heart failure. Heart failure in the geriatric population will continue to be a rising health burden globally, as this population represents the majority of the heart failure patients. Hence, rising geriatric population drives the demand for heart failure drugs during the forecast period.
The global Heart Failure Drugs market is valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Heart Failure Drugs market based on company, product type, end user and key regions.
This report studies the global market size of Heart Failure Drugs in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Heart Failure Drugs in these regions.
This research report categorizes the global Heart Failure Drugs market by top players/brands, region, type and end user. This report also studies the global Heart Failure Drugs market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.
The following manufacturers are covered in this report, with sales, revenue, market share for each company:
Amgen
AstraZeneca
Bayer
Novartis
Gilead
GlaxoSmithKline
Pfizer
Teva Pharmaceutical industries
Market size by Product
Beta Blockers
ARBs
ACE Inhibitors
Market size by End User
Hospital
Pharmacy
Others
Market size by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa
The study objectives of this report are:
To study and analyze the global Heart Failure Drugs market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
To understand the structure of Heart Failure Drugs market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Heart Failure Drugs companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of Heart Failure Drugs submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
In this study, the years considered to estimate the market size of Heart Failure Drugs are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
This report includes the estimation of market size for value (million US$) and volume (K MT). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Heart Failure Drugs market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
レポート目次Table of Contents
1 Study Coverage
1.1 Heart Failure Drugs Product
1.2 Market Segments
1.3 Key Manufacturers Covered
1.4 Market by Type
1.4.1 Global Heart Failure Drugs Market Size Growth Rate by Product
1.4.2 Beta Blockers
1.4.3 ARBs
1.4.4 ACE Inhibitors
1.5 Market by End User
1.5.1 Global Heart Failure Drugs Market Size Growth Rate by End User
1.5.2 Hospital
1.5.3 Pharmacy
1.5.4 Others
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Heart Failure Drugs Market Size
2.1.1 Global Heart Failure Drugs Revenue 2014-2025
2.1.2 Global Heart Failure Drugs Sales 2014-2025
2.2 Heart Failure Drugs Growth Rate by Regions
2.2.1 Global Heart Failure Drugs Sales by Regions
2.2.2 Global Heart Failure Drugs Revenue by Regions
3 Breakdown Data by Manufacturers
3.1 Heart Failure Drugs Sales by Manufacturers
3.1.1 Heart Failure Drugs Sales by Manufacturers
3.1.2 Heart Failure Drugs Sales Market Share by Manufacturers
3.1.3 Global Heart Failure Drugs Market Concentration Ratio (CR5 and HHI)
3.2 Heart Failure Drugs Revenue by Manufacturers
3.2.1 Heart Failure Drugs Revenue by Manufacturers (2014-2019)
3.2.2 Heart Failure Drugs Revenue Share by Manufacturers (2014-2019)
3.3 Heart Failure Drugs Price by Manufacturers
3.4 Heart Failure Drugs Manufacturing Base Distribution, Product Types
3.4.1 Heart Failure Drugs Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Heart Failure Drugs Product Type
3.4.3 Date of International Manufacturers Enter into Heart Failure Drugs Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Product
4.1 Global Heart Failure Drugs Sales by Product
4.2 Global Heart Failure Drugs Revenue by Product
4.3 Heart Failure Drugs Price by Product
5 Breakdown Data by End User
5.1 Overview
5.2 Global Heart Failure Drugs Breakdown Data by End User
6 North America
6.1 North America Heart Failure Drugs by Countries
6.1.1 North America Heart Failure Drugs Sales by Countries
6.1.2 North America Heart Failure Drugs Revenue by Countries
6.1.3 United States
6.1.4 Canada
6.1.5 Mexico
6.2 North America Heart Failure Drugs by Product
6.3 North America Heart Failure Drugs by End User
7 Europe
7.1 Europe Heart Failure Drugs by Countries
7.1.1 Europe Heart Failure Drugs Sales by Countries
7.1.2 Europe Heart Failure Drugs Revenue by Countries
7.1.3 Germany
7.1.4 France
7.1.5 UK
7.1.6 Italy
7.1.7 Russia
7.2 Europe Heart Failure Drugs by Product
7.3 Europe Heart Failure Drugs by End User
8 Asia Pacific
8.1 Asia Pacific Heart Failure Drugs by Countries
8.1.1 Asia Pacific Heart Failure Drugs Sales by Countries
8.1.2 Asia Pacific Heart Failure Drugs Revenue by Countries
8.1.3 China
8.1.4 Japan
8.1.5 Korea
8.1.6 India
8.1.7 Australia
8.1.8 Indonesia
8.1.9 Malaysia
8.1.10 Philippines
8.1.11 Thailand
8.1.12 Vietnam
8.1.13 Singapore
8.2 Asia Pacific Heart Failure Drugs by Product
8.3 Asia Pacific Heart Failure Drugs by End User
9 Central & South America
9.1 Central & South America Heart Failure Drugs by Countries
9.1.1 Central & South America Heart Failure Drugs Sales by Countries
9.1.2 Central & South America Heart Failure Drugs Revenue by Countries
9.1.3 Brazil
9.2 Central & South America Heart Failure Drugs by Product
9.3 Central & South America Heart Failure Drugs by End User
10 Middle East and Africa
10.1 Middle East and Africa Heart Failure Drugs by Countries
10.1.1 Middle East and Africa Heart Failure Drugs Sales by Countries
10.1.2 Middle East and Africa Heart Failure Drugs Revenue by Countries
10.1.3 GCC Countries
10.1.4 Turkey
10.1.5 Egypt
10.1.6 South Africa
10.2 Middle East and Africa Heart Failure Drugs by Product
10.3 Middle East and Africa Heart Failure Drugs by End User
11 Company Profiles
11.1 Amgen
11.1.1 Amgen Company Details
11.1.2 Company Business Overview
11.1.3 Amgen Heart Failure Drugs Sales, Revenue and Gross Margin (2014-2019)
11.1.4 Amgen Heart Failure Drugs Products Offered
11.1.5 Amgen Recent Development
11.2 AstraZeneca
11.2.1 AstraZeneca Company Details
11.2.2 Company Business Overview
11.2.3 AstraZeneca Heart Failure Drugs Sales, Revenue and Gross Margin (2014-2019)
11.2.4 AstraZeneca Heart Failure Drugs Products Offered
11.2.5 AstraZeneca Recent Development
11.3 Bayer
11.3.1 Bayer Company Details
11.3.2 Company Business Overview
11.3.3 Bayer Heart Failure Drugs Sales, Revenue and Gross Margin (2014-2019)
11.3.4 Bayer Heart Failure Drugs Products Offered
11.3.5 Bayer Recent Development
11.4 Novartis
11.4.1 Novartis Company Details
11.4.2 Company Business Overview
11.4.3 Novartis Heart Failure Drugs Sales, Revenue and Gross Margin (2014-2019)
11.4.4 Novartis Heart Failure Drugs Products Offered
11.4.5 Novartis Recent Development
11.5 Gilead
11.5.1 Gilead Company Details
11.5.2 Company Business Overview
11.5.3 Gilead Heart Failure Drugs Sales, Revenue and Gross Margin (2014-2019)
11.5.4 Gilead Heart Failure Drugs Products Offered
11.5.5 Gilead Recent Development
11.6 GlaxoSmithKline
11.6.1 GlaxoSmithKline Company Details
11.6.2 Company Business Overview
11.6.3 GlaxoSmithKline Heart Failure Drugs Sales, Revenue and Gross Margin (2014-2019)
11.6.4 GlaxoSmithKline Heart Failure Drugs Products Offered
11.6.5 GlaxoSmithKline Recent Development
11.7 Pfizer
11.7.1 Pfizer Company Details
11.7.2 Company Business Overview
11.7.3 Pfizer Heart Failure Drugs Sales, Revenue and Gross Margin (2014-2019)
11.7.4 Pfizer Heart Failure Drugs Products Offered
11.7.5 Pfizer Recent Development
11.8 Teva Pharmaceutical industries
11.8.1 Teva Pharmaceutical industries Company Details
11.8.2 Company Business Overview
11.8.3 Teva Pharmaceutical industries Heart Failure Drugs Sales, Revenue and Gross Margin (2014-2019)
11.8.4 Teva Pharmaceutical industries Heart Failure Drugs Products Offered
11.8.5 Teva Pharmaceutical industries Recent Development
12 Future Forecast
12.1 Heart Failure Drugs Market Forecast by Regions
12.1.1 Global Heart Failure Drugs Sales Forecast by Regions 2019-2025
12.1.2 Global Heart Failure Drugs Revenue Forecast by Regions 2019-2025
12.2 Heart Failure Drugs Market Forecast by Product
12.2.1 Global Heart Failure Drugs Sales Forecast by Product 2019-2025
12.2.2 Global Heart Failure Drugs Revenue Forecast by Product 2019-2025
12.3 Heart Failure Drugs Market Forecast by End User
12.4 North America Heart Failure Drugs Forecast
12.5 Europe Heart Failure Drugs Forecast
12.6 Asia Pacific Heart Failure Drugs Forecast
12.7 Central & South America Heart Failure Drugs Forecast
12.8 Middle East and Africa Heart Failure Drugs Forecast
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Macroscopic Indicators
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Heart Failure Drugs Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
Figure Heart Failure Drugs Product Picture
Table Heart Failure Drugs Market Segments
Table Key Manufacturers Heart Failure Drugs Covered
Table Global Heart Failure Drugs Market Size Growth Rate by Product 2019-2025 (K MT) & (Million US$)
Figure Global Heart Failure Drugs Sales Market Share by Product 2014-2025
Figure Beta Blockers Product Picture
Table Major Manufacturers of Beta Blockers
Figure ARBs Product Picture
Table Major Manufacturers of ARBs
Figure ACE Inhibitors Product Picture
Table Major Manufacturers of ACE Inhibitors
Table Global Heart Failure Drugs Market Size Growth Rate by End User 2019-2025 (K MT)
Figure Hospital
Figure Pharmacy
Figure Others
Figure Heart Failure Drugs Report Years Considered
Figure Global Heart Failure Drugs Market Size 2014-2025 (Million US$)
Figure Global Heart Failure Drugs Sales 2014-2025 (K MT)
Table Global Heart Failure Drugs Market Size by Regions 2014-2019 (K MT) & (Million US$)
Table Global Heart Failure Drugs Sales by Regions 2014-2019 (K MT)
Table Global Heart Failure Drugs Sales Market Share by Regions 2014-2019
Figure Global Heart Failure Drugs Sales Market Share by Regions 2014-2019
Figure 2018 Global Heart Failure Drugs Sales Market Share by Regions
Table Global Heart Failure Drugs Revenue by Regions 2014-2019 (Million US$)
Table Global Heart Failure Drugs Revenue Market Share by Regions 2014-2019
Figure Global Heart Failure Drugs Revenue Market Share by Regions 2014-2019
Figure 2018 Global Heart Failure Drugs Revenue Market Share by Regions
Table Global Heart Failure Drugs Sales by Manufacturers (2014-2019) (K MT)
Table Global Heart Failure Drugs Sales Share by Manufacturers (2014-2019)
Figure Global Heart Failure Drugs Sales Share by Manufacturers in 2018
Table Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Heart Failure Drugs Revenue by Manufacturers (2014-2019) (Million USD)
Table Heart Failure Drugs Revenue Share by Manufacturers (2014-2019)
Figure Heart Failure Drugs Value Share by Manufacturers in 2018
Table Key Manufacturers Heart Failure Drugs Price (2014-2019) (USD/MT)
Table Heart Failure Drugs Manufacturers Manufacturing Base Distribution and Headquarters
Table Manufacturers Heart Failure Drugs Product Type
Table Date of International Manufacturers Enter into Heart Failure Drugs Market
Table Manufacturers Mergers & Acquisitions, Expansion Plans
Table Global Heart Failure Drugs Sales by Product (2014-2019) (K MT)
Table Global Heart Failure Drugs Sales Share by Product (2014-2019)
Figure Global Heart Failure Drugs Sales Market Share by Product (2014-2019)
Figure Global Heart Failure Drugs Sales Market Share by Product in 2018
Table Global Heart Failure Drugs Revenue by Product (2014-2019) (Million US$)
Table Global Heart Failure Drugs Revenue Share by Product (2014-2019)
Figure Global Heart Failure Drugs Revenue Market Share by Product (2014-2019)
Figure Global Heart Failure Drugs Revenue Market Share by Product in 2018
Table Heart Failure Drugs Price by Product 2014-2019 (USD/MT)
Table Global Heart Failure Drugs Sales by End User (2014-2019) (K MT)
Table Global Heart Failure Drugs Sales Share by End User (2014-2019)
Figure Global Sales Heart Failure Drugs Market Share by End User (2014-2019)
Figure Global Sales Heart Failure Drugs Market Share by End User in 2018
Figure North America Heart Failure Drugs Sales Growth Rate 2014-2019 (K MT)
Figure North America Heart Failure Drugs Revenue Growth Rate 2014-2019 (Million US$)
Table North America Heart Failure Drugs Sales by Countries (2014-2019) (K MT)
Table North America Heart Failure Drugs Sales Market Share by Countries (2014-2019)
Figure 2018 North America Heart Failure Drugs Sales Market Share by Countries
Table North America Heart Failure Drugs Revenue by Countries (2014-2019) (Million US$)
Table North America Heart Failure Drugs Revenue Market Share by Countries (2014-2019)
Figure 2018 North America Heart Failure Drugs Revenue Market Share by Countries
Figure United States Heart Failure Drugs Sales Growth Rate (2014-2019) (K MT)
Figure United States Heart Failure Drugs Revenue Growth Rate (2014-2019) (K MT)
Figure Canada Heart Failure Drugs Sales Growth Rate (2014-2019) (K MT)
Figure Canada Heart Failure Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Mexico Heart Failure Drugs Sales Growth Rate (2014-2019) (K MT)
Figure Mexico Heart Failure Drugs Revenue Growth Rate (2014-2019) (Million US$)
Table North America Heart Failure Drugs Sales by Product (2014-2019) (K MT)
Table North America Heart Failure Drugs Sales Market Share by Product (2014-2019)
Figure 2018 North America Heart Failure Drugs Market Share by Product
Table North America Heart Failure Drugs Sales by End User (2014-2019) (K MT)
Table North America Heart Failure Drugs Sales Market Share by End User (2014-2019)
Figure 2018 North America Heart Failure Drugs Market Share by End User
Figure Europe Heart Failure Drugs Sales Growth Rate 2014-2019 (K MT)
Figure Europe Heart Failure Drugs Revenue Growth Rate 2014-2019 (Million US$)
Table Europe Heart Failure Drugs Sales by Countries (2014-2019) (K MT)
Table Europe Heart Failure Drugs Sales Market Share by Countries (2014-2019)
Figure 2018 Europe Heart Failure Drugs Sales Market Share by Countries
Table Europe Heart Failure Drugs Revenue by Countries (2014-2019) (Million US$)
Table Europe Heart Failure Drugs Revenue Market Share by Countries (2014-2019)
Figure 2018 Europe Heart Failure Drugs Revenue Market Share by Countries
Figure Germany Heart Failure Drugs Sales Growth Rate (2014-2019) (K MT)
Figure Germany Heart Failure Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure France Heart Failure Drugs Sales Growth Rate (2014-2019) (K MT)
Figure France Heart Failure Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure UK Heart Failure Drugs Sales Growth Rate (2014-2019) (K MT)
Figure UK Heart Failure Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Italy Heart Failure Drugs Sales Growth Rate (2014-2019) (K MT)
Figure Italy Heart Failure Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Russia Heart Failure Drugs Sales Growth Rate (2014-2019) (K MT)
Figure Russia Heart Failure Drugs Revenue Growth Rate (2014-2019) (Million US$)
Table Europe Heart Failure Drugs Sales by Product (2014-2019) (K MT)
Table Europe Heart Failure Drugs Sales Market Share by Product (2014-2019)
Figure 2018 Europe Heart Failure Drugs Market Share by Product
Table Europe Heart Failure Drugs Sales by End User (2014-2019) (K MT)
Table Europe Heart Failure Drugs Sales Market Share by End User (2014-2019)
Figure 2018 Europe Heart Failure Drugs Market Share by End User
Figure Asia Pacific Heart Failure Drugs Sales Growth Rate 2014-2019 (K MT)
Figure Asia Pacific Heart Failure Drugs Revenue Growth Rate 2014-2019 (Million US$)
Table Asia Pacific Heart Failure Drugs Sales by Countries (2014-2019) (K MT)
Table Asia Pacific Heart Failure Drugs Sales Market Share by Countries (2014-2019)
Figure 2018 Asia Pacific Heart Failure Drugs Sales Market Share by Countries
Table Asia Pacific Heart Failure Drugs Revenue by Countries (2014-2019) (Million US$)
Table Asia Pacific Heart Failure Drugs Revenue Market Share by Countries (2014-2019)
Figure 2018 Asia Pacific Heart Failure Drugs Revenue Market Share by Countries
Figure China Heart Failure Drugs Sales Growth Rate (2014-2019) (K MT)
Figure China Heart Failure Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Japan Heart Failure Drugs Sales Growth Rate (2014-2019) (K MT)
Figure Japan Heart Failure Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Korea Heart Failure Drugs Sales Growth Rate (2014-2019) (K MT)
Figure Korea Heart Failure Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure India Heart Failure Drugs Sales Growth Rate (2014-2019) (K MT)
Figure India Heart Failure Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Australia Heart Failure Drugs Sales Growth Rate (2014-2019) (K MT)
Figure Australia Heart Failure Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Indonesia Heart Failure Drugs Sales Growth Rate (2014-2019) (K MT)
Figure Indonesia Heart Failure Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Malaysia Heart Failure Drugs Sales Growth Rate (2014-2019) (K MT)
Figure Malaysia Heart Failure Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Philippines Heart Failure Drugs Sales Growth Rate (2014-2019) (K MT)
Figure Philippines Heart Failure Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Thailand Heart Failure Drugs Sales Growth Rate (2014-2019) (K MT)
Figure Thailand Heart Failure Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Vietnam Heart Failure Drugs Sales Growth Rate (2014-2019) (K MT)
Figure Vietnam Heart Failure Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Singapore Heart Failure Drugs Sales Growth Rate (2014-2019) (K MT)
Figure Singapore Heart Failure Drugs Revenue Growth Rate (2014-2019) (Million US$)
Table Asia Pacific Heart Failure Drugs Sales by Product (2014-2019) (K MT)
Table Asia Pacific Heart Failure Drugs Sales Market Share by Product (2014-2019)
Figure 2018 Asia Pacific Heart Failure Drugs Market Share by Product
Table Asia Pacific Heart Failure Drugs Sales by End User (2014-2019) (K MT)
Table Asia Pacific Heart Failure Drugs Sales Market Share by End User (2014-2019)
Figure 2018 Asia Pacific Heart Failure Drugs Market Share by End User
Figure Central & South America Heart Failure Drugs Sales Growth Rate 2014-2019 (K MT)
Figure Central & South America Heart Failure Drugs Revenue Growth Rate 2014-2019 (Million US$)
Table Central & South America Heart Failure Drugs Sales by Countries (2014-2019) (K MT)
Table Central & South America Heart Failure Drugs Sales Market Share by Countries (2014-2019)
Figure 2018 Central & South America Heart Failure Drugs Sales Market Share by Countries
Table Central & South America Heart Failure Drugs Revenue by Countries (2014-2019) (Million US$)
Table Central & South America Heart Failure Drugs Revenue Market Share by Countries (2014-2019)
Figure 2018 Central & South America Heart Failure Drugs Revenue Market Share by Countries
Figure Brazil Heart Failure Drugs Sales Growth Rate (2014-2019) (K MT)
Figure Brazil Heart Failure Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Argentina Heart Failure Drugs Sales Growth Rate (2014-2019) (K MT)
Figure Argentina Heart Failure Drugs Revenue Growth Rate (2014-2019) (Million US$)
Table Central & South America Heart Failure Drugs Sales by Product (2014-2019) (K MT)
Table Central & South America Heart Failure Drugs Sales Market Share by Product (2014-2019)
Figure 2018 Central & South America Heart Failure Drugs Market Share by Product
Table Central & South America Heart Failure Drugs Sales by End User (2014-2019) (K MT)
Table Central & South America Heart Failure Drugs Sales Market Share by End User (2014-2019)
Figure 2018 Central & South America Heart Failure Drugs Market Share by End User
Figure Middle East and Africa Heart Failure Drugs Sales Growth Rate 2014-2019 (K MT)
Figure Middle East and Africa Heart Failure Drugs Revenue Growth Rate 2014-2019 (Million US$)
Table Middle East and Africa Heart Failure Drugs Sales by Countries (2014-2019) (K MT)
Table Middle East and Africa Heart Failure Drugs Sales Market Share by Countries (2014-2019)
Figure 2018 Middle East and Africa Heart Failure Drugs Sales Market Share by Countries
Table Middle East and Africa Heart Failure Drugs Revenue by Countries (2014-2019) (Million US$)
Table Middle East and Africa Heart Failure Drugs Revenue Market Share by Countries (2014-2019)
Figure 2018 Middle East and Africa Heart Failure Drugs Revenue Market Share by Countries
Figure GCC Countries Heart Failure Drugs Sales Growth Rate (2014-2019) (K MT)
Figure GCC Countries Heart Failure Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Turkey Heart Failure Drugs Sales Growth Rate (2014-2019) (K MT)
Figure Turkey Heart Failure Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Egypt Heart Failure Drugs Sales Growth Rate (2014-2019) (K MT)
Figure Egypt Heart Failure Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure South Africa Heart Failure Drugs Sales Growth Rate (2014-2019) (K MT)
Figure South Africa Heart Failure Drugs Revenue Growth Rate (2014-2019) (Million US$)
Table Middle East and Africa Heart Failure Drugs Sales by Product (2014-2019) (K MT)
Table Middle East and Africa Heart Failure Drugs Sales Market Share by Product (2014-2019)
Figure 2018 Middle East and Africa Heart Failure Drugs Market Share by Product
Table Middle East and Africa Heart Failure Drugs Sales by End User (2014-2019) (K MT)
Table Middle East and Africa Heart Failure Drugs Sales Market Share by End User (2014-2019)
Figure 2018 Middle East and Africa Heart Failure Drugs Market Share by End User
Table Amgen Company Details
Table Amgen Heart Failure Drugs Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2014-2019)
Table Amgen Recent Development
Table AstraZeneca Company Details
Table AstraZeneca Heart Failure Drugs Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2014-2019)
Table AstraZeneca Recent Development
Table Bayer Company Details
Table Bayer Heart Failure Drugs Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2014-2019)
Table Bayer Recent Development
Table Novartis Company Details
Table Novartis Heart Failure Drugs Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2014-2019)
Table Novartis Recent Development
Table Gilead Company Details
Table Gilead Heart Failure Drugs Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2014-2019)
Table Gilead Recent Development
Table GlaxoSmithKline Company Details
Table GlaxoSmithKline Heart Failure Drugs Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2014-2019)
Table GlaxoSmithKline Recent Development
Table Pfizer Company Details
Table Pfizer Heart Failure Drugs Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2014-2019)
Table Pfizer Recent Development
Table Teva Pharmaceutical industries Company Details
Table Teva Pharmaceutical industries Heart Failure Drugs Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2014-2019)
Table Teva Pharmaceutical industries Recent Development
Table Global Heart Failure Drugs Sales Forecast by Regions 2019-2025 (K MT)
Table Global Heart Failure Drugs Sales Market Share Forecast by Regions 2019-2025
Table Global Heart Failure Drugs Revenue Forecast by Regions 2019-2025 (Million US$)
Table Global Heart Failure Drugs Revenue Market Share Forecast by Regions 2019-2025
Table Global Heart Failure Drugs Sales Forecast by Product 2019-2025 (K MT)
Table Global Heart Failure Drugs Sales Market Share Forecast by Product 2019-2025
Table Global Heart Failure Drugs Revenue Forecast by Product 2019-2025 (Million US$)
Table Global Heart Failure Drugs Revenue Market Share Forecast by Product 2019-2025
Table Global Heart Failure Drugs Sales Forecast by End User 2019-2025 (K MT)
Table Global Heart Failure Drugs Sales Market Share Forecast by End User 2019-2025
Figure North America Heart Failure Drugs Sales Growth Rate Forecast (2019-2025) (K MT)
Figure North America Heart Failure Drugs Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Europe Heart Failure Drugs Sales Growth Rate Forecast (2019-2025) (K MT)
Figure Europe Heart Failure Drugs Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Asia Pacific Heart Failure Drugs Sales Growth Rate Forecast (2019-2025) (K MT)
Figure Asia Pacific Heart Failure Drugs Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Central & South America Heart Failure Drugs Sales Growth Rate Forecast (2019-2025) (K MT)
Figure Central & South America Heart Failure Drugs Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Middle East and Africa Heart Failure Drugs Sales Growth Rate Forecast (2019-2025) (K MT)
Figure Middle East and Africa Heart Failure Drugs Revenue Growth Rate Forecast (2019-2025) (Million US$)
Table Heart Failure Drugs Value Chain
Table Heart Failure Drugs Customers List
Table Heart Failure Drugs Distributors List
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
虚血性心疾患（IHD）医薬品の世界市場：インサイト・予測 Ischemic heart disease (IHD), refers to a group of diseases which includes stable angina, unstable angina, myocardial infarction, and sudden cardiac death. It is within the group of cardiovascular diseases of which it is the most common type. A common symptom is chest pain or discomfort which may tr…- 急性腎不全治療薬の世界市場：市場規模・現状・予測 Acute renal failure is a sudden loss of kidney’s ability to eliminate excess fluids, salts and metabolic waste from the body. It leads to accumulation of metabolic waste and electrolytes in the body which can be life-threatening. Kidney eliminates creatinine (Metabolic waste) from the body.Acute ren…
- 世界の故障解析テスト機器市場：専門的調査 Failure analysis is the process of collecting and analyzing data to determine the cause of a failure, often with the goal of determining corrective actions or liability. The global Failure Analysis Test Equipment market was valued at xx million US$ in 2018 and will reach xx million US$ by the end of…
- 吸収性ハートステントの世界市場：インサイト・予測 Stents are usually needed when plaque blocks a blood vessel. Plaque is made of cholesterol and other substances that attach to the walls of a vessel.Absorbable stents are the ones which get dissolved in the body over the period of time. Absorbable stents are made up of material that may be easily ab…
- 心臓健康機能性食品の世界市場：インサイト・予測 A functional food is a food given an additional function (often one related to health-promotion or disease prevention) by adding new ingredients or more of existing ingredients. The term may also apply to traits purposely bred into existing edible plants, such as purple or gold potatoes having enric…